CELGENE
Celgene Corporation
Mark For: CELGENE® trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 76515116 |
| Registration Number | 2888517 |
| Mark Literal Elements | CELGENE |
| Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
| Mark Type | TRADEMARK. SERVICE MARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Affidavit Text | SECT 15. SECT 8 (6-YR). PARTIAL SECTION 8(10-YR) 20131002. |
| Affidavit Text | 1ST RENEWAL 20131002 |
| Current Location | TMEG LAW OFFICE 105 2013-10-02 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | Yes |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Cancellation Code | B |
| Attorney Name | Camille M. Miller |
| Attorney Docket Number | CELG-0053-US |
| Law Office Assigned | L50 |
| Employee Name | POWERS, ALEXANDER L |
Timeline
| 1986-12-31 | Date of First Use |
| 1986-12-31 | Date of Use In Commerce |
| 1ST RENEWAL 20131002 | Renewal Date |
| 2003-05-19 | Application Filed |
| 2004-07-06 | Published |
| 2004-07-06 | Published for Opposition |
| 2004-09-28 | Trademark Registered |
| 2013-10-02 | Location: TMEG LAW OFFICE 105 |
| 2013-10-02 | Status: Live/Registered |
| 2013-10-02 | Status: The registration has been renewed. |
| 2014-09-28 | Renewal Date |
| 2019-12-26 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Celgene Corporation |
| Address | 86 Morris Avenue Summit, NEW JERSEY UNITED STATES 07901 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | IMAGE/TIFF | 2003-05-19 |
| Drawing | IMAGE/TIFF | 2003-05-19 |
 Specimen | 2003-05-19 | |
| XSearch Search Summary | 2003-12-04 | |
| Offc Action Outgoing | 2003-12-10 | |
| Response to Office Action | 2003-12-19 | |
| Examiners Amendment | 2004-04-30 | |
| Notation to File | 2004-04-30 | |
| Notice of Publication | 2004-06-16 | |
| Registration Certificate | IMAGE/TIFF | 2004-09-28 |
| Teas Change of Owner Address | 2005-06-16 | |
| Section 8 and 15 | 2009-10-02 | |
| Specimen | 2009-10-02 | |
| Notice of Acceptance Acknowledgement | 2009-10-20 | |
| PR-Section 8 and 9 | 2013-09-30 | |
| Specimen | 2013-09-30 | |
| Notice Of Acceptance | 2013-10-02 | |
| Notice Of Renewal | 2013-10-02 | |
| Notice Of Acceptance | 2013-10-03 | |
| Change of Address | 2015-07-28 | |
| NOS Notice of Suit Incoming | 2020-04-20 | |
| NOS Notice of Suit Incoming | 2020-09-10 |
Attorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: biochemical catalysts for use in medical research; biological preparations for medical purposes, namely, for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; [ enzyme preparations for industrial purposes; enzymes for industrial purposes; ] proteins for [ industrial and ] human consumption, namely, animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; [ chemical preparations used to protect crops in the agricultural and horticultural field; ] medicinal and biological preparations for medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system. FIRST USE: 19861231. FIRST USE IN COMMERCE: 19861231
IC 005. US 006 018 044 046 051 052. G & S: biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical and clinical use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system. FIRST USE: 19861231. FIRST USE IN COMMERCE: 19861231(CANCELLED)
IC 040. US 100 103 106. G & S: [ manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others ]. FIRST USE: 19861231. FIRST USE IN COMMERCE: 19861231
IC 041. US 100 101 107. G & S: educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith. FIRST USE: 19861231. FIRST USE IN COMMERCE: 19861231
IC 042. US 100 101. G & S: research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely, pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others [ ; agrochemical product development for others ]. FIRST USE: 19861231. FIRST USE IN COMMERCE: 19861231
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF SUIT | 2020-09-10 | |
| NOTICE OF SUIT | 2020-04-20 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2015-07-28 | |
| NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED | 2013-10-03 | |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2013-10-02 | 69471 |
| REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 | 2013-10-02 | 69471 |
| REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED | 2013-10-02 | 69471 |
| NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | 2013-10-02 | |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2013-10-02 | 69471 |
| TEAS SECTION 8 & 9 RECEIVED | 2013-09-30 | |
| REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED | 2013-09-30 | 69471 |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2009-10-20 | 69934 |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2009-10-20 | 69934 |
| TEAS SECTION 8 & 15 RECEIVED | 2009-10-02 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2005-06-16 | |
| REGISTERED-PRINCIPAL REGISTER | 2004-09-28 | |
| PUBLISHED FOR OPPOSITION | 2004-07-06 | |
| NOTICE OF PUBLICATION | 2004-06-16 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2004-04-30 | |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2004-04-19 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2004-02-15 | |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2003-12-19 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-12-19 | |
| NON-FINAL ACTION MAILED | 2003-12-12 | |
| ASSIGNED TO EXAMINER | 2003-11-29 | 73363 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 